arrow_back Back to App

Mandatory Naloxone Access and Training in Federal Prisons to Prevent Overdoses.

This law mandates that the Federal Bureau of Prisons must ensure life-saving opioid antagonist kits (like Naloxone) are readily available across all federal correctional facilities. Both staff and incarcerated individuals will receive annual training on how to recognize and respond to overdoses. Crucially, the law protects incarcerated persons from liability if they administer the medication in good faith to save a life.
Key points
Requires federal prisons to stock adequate supplies of opioid antagonist kits (Naloxone) in all key areas, including housing units and visiting areas.
Mandates annual training for both prison personnel and incarcerated persons on overdose recognition and Naloxone administration.
Provides legal protection for incarcerated individuals who administer Naloxone in good faith during an overdose emergency.
Authorizes $6 million in initial funding for training and purchasing the life-saving medication.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_6789
Sponsor: Rep. Foushee, Valerie P. [D-NC-4]
Process start date: 2025-12-17
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Federal Prisons Naloxone Access Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_6789.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-12-17.

What are the main provisions?

Key points include:

  • Requires federal prisons to stock adequate supplies of opioid antagonist kits (Naloxone) in all key areas, including housing units and visiting areas.
  • Mandates annual training for both prison personnel and incarcerated persons on overdose recognition and Naloxone administration.
  • Provides legal protection for incarcerated individuals who administer Naloxone in good faith during an overdose emergency.
  • Authorizes $6 million in initial funding for training and purchasing the life-saving medication.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Foushee, Valerie P. [D-NC-4].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on the Judiciary.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-21.

CATEGORIES

Health Courts and Law Security